跳至主要内容
临床试验/ISRCTN54273114
ISRCTN54273114已完成不适用

A Prospective Double-Blind, Randomized Clinical Trial of Levocarnitine to Treat Autism Spectrum Disorders

Autism Research Institute (USA)0 个研究点目标入组 30 人开始时间: 2010年3月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Subjects diagnosed with an ASD
  • 2. Aged from 3 to 10 yrs-old (males and females)
  • 3. Study subject bodyweights between 13.2 Kg to 40.4 Kg

排除标准

  • 1. No study subject previously received carnitine-based therapy or previous methionine or lysine supplementation
  • 2. No study subject had any change in therapy or treatment (including medications) within 1 month prior to the study

研究者

发起方
Autism Research Institute (USA)

相似试验